Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;37(4):491-495.
doi: 10.1007/s11596-017-1762-4. Epub 2017 Aug 8.

ω-3PUFAs prevent MK-801-induced cognitive impairment in schizophrenic rats via the CREB/BDNF/TrkB pathway

Affiliations

ω-3PUFAs prevent MK-801-induced cognitive impairment in schizophrenic rats via the CREB/BDNF/TrkB pathway

Mao-Sheng Fang et al. J Huazhong Univ Sci Technolog Med Sci. 2017 Aug.

Abstract

This study was to determine the protective effect of ω-3 polyunsaturated fatty acids (ω-3PUFAs) on MK-801-induced cognitive impairment in schizophrenia (SZ) rats and the underlying mechanism. A rat model of schizophrenia was induced by MK-801. The cognitive function of rats was assessed using a Morris water maze. The number of hippocampal neurons was measured by Nissl staining. The expression of CREB, p-CREB, BDNF, TrkB, p-TrkB, AKT, p-AKT, ERK, and p-ERK in the hippocampus of rats was detected by Western blotting. The results showed that ω-3PUFAs attenuated MK-801-induced cognitive impairment and hippocampal neurons loss, reversed the injury of the CREB/BDNF/TrkB pathway induced by MK-801, and antagonized MK-801-induced down-regulation of p-AKT and p-ERK in the hippocampus of rats. In conclusion, ω-3PUFAs enhances the CREB/BDNF/TrkB pathway by activating ERK and AKT, thereby increasing the synaptic plasticity and decreasing neuron loss, and antagonizing MK-801-induced cognitive impairment in schizophrenic rats.

Keywords: CREB/BDNF/TrkB pathway; MK-801; cognition impairment; schizophrenia; ω-3 polyunsaturated fatty acids.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Tunis Med. 2009 Oct;87(10):664-9 - PubMed
    1. Curr Opin Clin Nutr Metab Care. 2013 Nov;16(6):726-33 - PubMed
    1. CNS Drugs. 2003;17(15):1081-91 - PubMed
    1. J Lipid Res. 2004 Jan;45(1):71-80 - PubMed
    1. Neuroscientist. 2008 Apr;14(2):147-56 - PubMed

MeSH terms

Substances

LinkOut - more resources